Ethanol is named as an intervention in 3 current clinical trials in our China, France and Netherlands registers. 2 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Yunlong Wang (1). The most-studied condition is Atrial Fibrillation (AF).
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients
NCT03883269 · ClinicalTrials.gov ↗ · Acne Vulgaris
|
Phase 4 | Recruiting | Centre for Human Drug Research, Netherlands | Netherlands |
|
Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients
NCT03083184 · ClinicalTrials.gov ↗ · Tunnelled Hemodialysis Catheter Infection
|
Phase 3 | Recruiting | University Hospital, Clermont-Ferrand | France |
|
The COMBINE-AF Trial
NCT07633509 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Atrial Fibrillation Catheter Ablation
|
Not applicable | Not yet open | Yunlong Wang | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Yunlong Wang | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| Centre for Human Drug Research, Netherlands | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 1 | 0 |
| Clinical trials in France | 1 | 1 |
| Clinical trials in Netherlands | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our China, France and Netherlands registers name Ethanol as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 3 trials are recruiting: 1 with sites in France and 1 with sites in Netherlands. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Yunlong Wang (1), University Hospital, Clermont-Ferrand (1) and Centre for Human Drug Research, Netherlands (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Ethanol works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Ethanol works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Ethanol (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.